製薬 × マーケットアクセス / プライシング / HEOR の求人情報一覧
-
求人番号：JN -032026-201689 掲載日：2026-03-18
マーケットアクセス担当者
医療政策渉外に関わる業界活動の経験をお持ちの方必見です1000 - 1200 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は、医薬品の研究、開発、製造、販売および輸出を行っています。独立した自主経営・研究、開発、生産、販売一全機能の保有・独自の国際展開の継続・研究開発力の強化に取り組み、「がん」領域をはじめとする戦略領域を中心に、抗体医薬品を含む有望な新薬の創出を加速しています。またグローバル展開も積極的に行い、世界中の患者に対し、高品質な医薬品とサービスを提供しています。
- 業務内容
- 渉外調査部および製品チームに所属して頂き、社内外のマルチステークホルダーとコミュニケーションを密に取りながら、価格・アクセス戦略および医療政策対応を推進して頂く役割です。（以下は例示）
製品担当：担当製品の価格・アクセス戦略の検討・推進
薬価等実務：新薬や既収載薬、医療機器の価格・保険適用手続き全般など
医療政策渉外担当：費用対効果評価制度等に関する業界団体等での政策提言活動など
Go Ozawa
Industrial & Life Science -
求人番号：JN -072024-166756 掲載日：2026-01-28
Access Strategy Senior Manager
Senior Manager position at global mega pharma1200 - 1800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- Overview:Develop a compelling access strategy tailored for New Asset to stakeholder interests and needs and leads strategic & tactical planning for market access activities to ensure optimal patient access with appropriate price setting.
Drive a Local/Regional/Global cross-functional team to develop and implement access strategies for assigned assets.
Scrutinize the commercialization plan for the assigned asset from pricing &reimbursement perspectives
Obtain endorsements from TA Leads to implement access strategies.
Main Responsibilities:Develop and implement access plans for assigned assets, which include scenario-based pricing assumptions with strategic initiatives, secure patient access and identify opportunities for accelerating launch timing.
Investigate and build deep understandings of key stakeholders’ (payers, market access customers) needs and reflect these insights into business/access planning processes via leveraging real-world databases and information in the following areas: Epidemiology: Patient dynamics, pathology, genetic background, Diagnosis & treatment guidelines
Market Environment: Current market size, competitive landscape analysis
Physician/Patient/Payer Insights: Unmet medical needs, burden of Disease/QOL
Local/Overseas access environment: Policy, HTA/Reimbursement system
Lead discussions and presentations to senior management to get required funding for launch optimization projects, including HEOR, HTA, RWD based data generation, as well as unbranded campaigns, etc., identified through cross functional discussion.
Work in close alignment and cooperation with a cross-section of colleagues (Global Access & Value, Global Commercial Development, Global Medicine Team, MA, DJ, Business Unit, A&V, P&PA, and BAI) through JMT/JVT/JAT.
Participate in JDC/J-PRC for portfolio entry, Global DP3 and Japan buy-up etc. through asset assessment in related TA as required.
Develop and include value claims for the brand at NDA to support optimal access.
Support NAA on developing reasonably accurate Long-rage revenue/expense/demand forecast for company pipeline assets and BD projects until 18 months prior to approval.
Support NAA on developing data, insights and recommendations for Strategic Plans that include strategies, tactics, and programs to maximize the long-term potential of development compounds, and obtain senior management endorsement.
Yui Osone
Industrial & Life Science -
求人番号：JN -072024-38976 掲載日：2026-01-28
Director: RWE Partnerships & Innovation
Director position at global mega pharma1600 - 3000 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- The RWE Partnerships and Platforms organization functions to:Enhance company's ability to determine unmet medical needs;
Support differentiated product labels for Product Development programs including finding alternatives and accelerated licensure pathways for new indications through the use of Real World Data (RWD), Real World Insights (RWI) and Real World Evidence (RWE);
Inform clinical practice on appropriate prescription and use of company products;
In collaboration with Access & Value, strengthen the value evidence package for payers and access/policy decision-makers;
Support measurement of short- and long-term impact of company products to both patients and populations;
Support competitive differentiation.
This position will serve as the Real World Data point of contact for either one category or one geographic region.Execute on prioritized tactical plans with actionable projects, identify external partners to deliver strategic RWE capabilities / data, and oversight of high quality methods and designs to inform study / project designs for R&D franchise / asset teams, CMAO, Health Economics and Outcomes Research, Commercial and other functions’ needs
Provide daily mentorship, motivation, and guidance to more junior RWE colleagues, & direct them to co-develop emerging, core a strategic partnerships with commercial and academic data suppliers
Supports landscape assessments, new data / tool / partner due diligence assessments based on understanding evolving healthcare, technology and other industries with Customers, RWE Digital platform team, Digital RWD Enterprise Enabling Platform, RWE Biostatistics and other relevant partners
Documents all requests and track progress toward project completion, other metrics and business goals
Develops training materials for ensuring colleagues understanding and competency in various aspects of the RWE process
Communicates critical knowledge on business processes to relevant stakeholders
Yui Osone
Industrial & Life Science -
求人番号：JN -072024-37929 掲載日：2024-09-11
Pricing & External Affairs Senior Manager
Pricing Senior Manager position at global mega pharma1200 - 1800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- Responsibilities
Develop strategic NHI pricing strategies and gain endorsement of NHI pricing strategies and proposals of NHI prices with Country President and TA Leads through the Pricing Committee
Develop robust pricing dossiers and strategically manage price negotiations
Build strong alignment & partnership among Japan Pricing Core members (New Asset & Access Strategy team, New Asset Analysis team, DJ, Medical, Launch Excellence Team, Policy and Public Affairs, and the global PHI) to ensure optimal price setting
Develop Pricing-related OP assumptions
Refresh pricing assumptions and estimated prices for pipeline products and BD assets to reflect the latest competitive environment
Minimize the downward price adjustment by price revision/repricing through cross-functional collaboration
Maintain good relationship with “Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, MHLW” (former EAD) and act as a mediator between the company and MHLW to flawlessly manage all product-related issues, as well as NHI pricing negotiation
Actively participate in trade association activities (FPMAJ, PhRMA, FIRM, etc.) to establish a pro-innovative pricing framework
Contribute to building a high performing team by actively engaging in coaching junior colleagues and nurturing a positive environment where people feel energized and eager to speak up
Yui Osone
Industrial & Life Science
1